COLUMBUS
Pfizer
Pfizer
H. Lee Moffitt Cancer Center and Research Institute
Adaptimmune
Pierre Fabre Medicament
Abramson Cancer Center at Penn Medicine
Vedanta Biosciences, Inc.
Eisai Inc.
Anaveon AG
Incyte Corporation
Incyte Corporation
Leap Therapeutics, Inc.
Biogen
Biogen
Grupo Español Multidisciplinar de Melanoma
Scholar Rock, Inc.
Cedars-Sinai Medical Center
Actelion
Altor BioScience
National Cancer Institute (NCI)
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
National Cancer Institute (NCI)
Cedars-Sinai Medical Center
Rockefeller University
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
NextCure, Inc.
Centre Hospitalier Universitaire de Nice
Rutgers, The State University of New Jersey
Perspective Therapeutics
Eastern Cooperative Oncology Group
Providence Health & Services
Nektar Therapeutics
Herlev Hospital
Quadriga Biosciences, Inc.
Grupo Español Multidisciplinar de Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Nantes University Hospital
Bristol-Myers Squibb
Pfizer
University of Kansas Medical Center
M.D. Anderson Cancer Center
Northwestern University
Eisai Inc.
M.D. Anderson Cancer Center
Delcath Systems Inc.
National Institutes of Health Clinical Center (CC)
Pfizer
Novartis
Incyte Corporation